Cas:138984-26-6 dirhodium (ii) tetrakis(caprolactam) manufacturer & supplier

We serve Chemical Name:dirhodium (ii) tetrakis(caprolactam) CAS:138984-26-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dirhodium (ii) tetrakis(caprolactam)

Chemical Name:dirhodium (ii) tetrakis(caprolactam)
CAS.NO:138984-26-6
Synonyms:Dirhodium(II) tetrakis(caprolactam),complex with acetonitrile (1:2);MFCD00467690;Dirhodium tetracaprolactamate;dirhodium tetrakis(caprolactamate);DOYLE DIRHODIUM CATALYST-RH2(CAPY)4;Rh2(caprolactamate)4;dirhodium(II) tetrakiscaprolactam
Molecular Formula:C24H44N4O4Rh2
Molecular Weight:658.44200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:116.40000
Exact Mass:658.14700
LogP:4.02160

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Dirhodium(II) tetrakis(caprolactam),complex with acetonitrile (1:2) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dirhodium(II) tetrakiscaprolactam physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Rh2(caprolactamate)4 Use and application,Rh2(caprolactamate)4 technical grade,usp/ep/jp grade.


Related News: It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. dirhodium (ii) tetrakis(caprolactam) manufacturer From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. dirhodium (ii) tetrakis(caprolactam) supplier The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun. dirhodium (ii) tetrakis(caprolactam) vendor A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. dirhodium (ii) tetrakis(caprolactam) factory It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said.